$VPHM News Morgan Stanley drops Google from best
Post# of 145160
Posted On: 11/11/2013 8:09:27 PM
$VPHM News
Morgan Stanley drops Google from best idea list 4:25 p.m. Today - Sue Chang
Shire up in London; BSkyB, ITV off after BT soccer deal 12:10 p.m. Today - Sara Sjolin
Strong Chinese data lift European markets 12:09 p.m. Today - Sara Sjolin
Stock futures higher; Twitter, ViroPhama in spotlight 7:54 a.m. Today - Barbara Kollmeyer
ViroPharma surges 26.5% premarket on Shire buyout 7:27 a.m. Today - Ben Eisen
Shire pays $4.2B for rare-disease firm ViroPharma 2:54 a.m. Today - MarketWatch.com
Powerful market uptrend meets seasonal tailwind 11:11 a.m. Nov. 1, 2013 - Michael Ashbaugh
ViroPharma shares soar on news of interest from two overseas buyers 5:09 p.m. Sept. 13, 2013 - Russ Britt
S&P 500 retests its one-decade breakout point 10:37 a.m. June 24, 2013 - Michael Ashbaugh
ViroPharma soars on buyout rumors 1:27 p.m. June 17, 2013 - Russ Britt
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
Blood disease medication earns ViroPharma upbeat analyst reviews 12:43 p.m. March 27, 2013 - Russ Britt
Ratings hit three health firms; upgrade helps one 6:12 p.m. Jan. 15, 2013 - Russ Britt
Friday’s biggest gaining and declining stocks 3:14 p.m. Sept. 21, 2012 - Greg Morcroft
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
ViroPharma up 15% on FDA nod 2:25 p.m. Aug. 6, 2012 - Val Brickates Kennedy
ViroPharma has FDA nod to expand Cinryze 1:19 p.m. Aug. 6, 2012 - MarketWatch.com
Knight Capital, E-Trade options volumes soar 10:06 a.m. Aug. 2, 2012 - blogs.marketwatch.com
Benzinga's M&A Chatter for Monday November 11, 2013 5:31 p.m. Today - benzinga.com
ViroPharma Larger Than S&P 500 Component JDS Uniphase 4:39 p.m. Today - TheStreet.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Today - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Today - Investors Business Daily
Intel Buys ‘Kno’ to Reinforce Education Laptops Sideline and 2 Other Hot Stocks to Watch 11:35 a.m. Today - Wall St. Cheat Sheet
Shire's Growth Carries Swollen Price Tag 11:27 a.m. Today - WSJ.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Today - Investors Business Daily
Mid-Morning Market Update: Markets Edge Higher; Shire To Acquire ViroPharma For $4.2B 9:37 a.m. Today - benzinga.com
Shire Shells Out $4.2B to Buy ViroPharma 9:15 a.m. Today - FOXBusiness
Morning Market Movers 9:11 a.m. Today - benzinga.com
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Today - WSJ.com
Today's Pre-Market Mover With Heavy Volume: ViroPharma (VPHM) 7:48 a.m. Today - TheStreet.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Today - 247WallSt.com
Shire Buying Viropharma for $4.2B to Bolster Rare Disease Unit 6:34 a.m. Today - TheStreet.com
Wall Street Breakfast: Must-Know News 6:34 a.m. Today - Seeking Alpha
The Deal: Shire to Spend $4.2 Billion on ViroPharma 6:33 a.m. Today - TheStreet.com
Nov. 11 Premarket Briefing: 10 Things You Should Know 5:54 a.m. Today - TheStreet.com
The Deal: Overseas Stocks Trade Mixed; Nikkei Rises 1.3% 5:43 a.m. Today - TheStreet.com
Shire to Acquire ViroPharma for $50,00/Share in Cash 5:09 a.m. Today - benzinga.com
ViroPharma's Core Business Is Accelerating, New Opportunities Emerge 11:33 a.m. Nov. 6, 2013 - Seeking Alpha
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. 5:24 p.m. Today - PR Newswire
SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout 4:09 p.m. Today - BusinessWire
Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal 3:23 p.m. Today - BusinessWire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2:33 p.m. Today - BusinessWire
ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire 12:17 p.m. Today - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 11:15 a.m. Today - BusinessWire
VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ViroPharma Inc. (VPHM) Over the Proposed Sale of the Company to Shire (SHPG) in a Cash Deal 11:14 a.m. Today - BusinessWire
Law Firm Brower Piven Announces Investigation of ViroPharma Incorporated Proposed Buyout 11:08 a.m. Today - BusinessWire
Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC. 10:42 a.m. Today - PR Newswire
GOGO, CLDX, VPHM and ARNA Added to NASDAQ Active Stock Watch List at EPR 10:15 a.m. Today - ACCESSWIRE
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ViroPharma, Inc. 8:45 a.m. Today - PR Newswire
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects 2:00 a.m. Today - PR Newswire
ViroPharma Announces Upcoming Data Presentations at the 2013 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting 2:29 p.m. Nov. 6, 2013 - PR Newswire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ViroPharma Incorporated Reports Third Quarter 2013 Financial Results 6:30 a.m. Oct. 31, 2013 - PR Newswire
ViroPharma To Release 2013 Third Quarter Financial Results On October 31, 2013 11:00 a.m. Oct. 28, 2013 - PR Newswire
ViroPharma To Participate In The Leerink Swann Rare Disease Conference 10:00 a.m. Sept. 27, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ONCY, RMTI, TEVA and VPHM 8:01 a.m. Sept. 16, 2013 - ACCESSWIRE
ViroPharma To Participate In The Stifel Nicolaus 2013 Healthcare Conference 2:00 p.m. Sept. 9, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on STMP, SRDX, VMC and VPHM 7:41 a.m. Aug. 2, 2013 - ACCESSWIRE
Morgan Stanley drops Google from best idea list 4:25 p.m. Today - Sue Chang
Shire up in London; BSkyB, ITV off after BT soccer deal 12:10 p.m. Today - Sara Sjolin
Strong Chinese data lift European markets 12:09 p.m. Today - Sara Sjolin
Stock futures higher; Twitter, ViroPhama in spotlight 7:54 a.m. Today - Barbara Kollmeyer
ViroPharma surges 26.5% premarket on Shire buyout 7:27 a.m. Today - Ben Eisen
Shire pays $4.2B for rare-disease firm ViroPharma 2:54 a.m. Today - MarketWatch.com
Powerful market uptrend meets seasonal tailwind 11:11 a.m. Nov. 1, 2013 - Michael Ashbaugh
ViroPharma shares soar on news of interest from two overseas buyers 5:09 p.m. Sept. 13, 2013 - Russ Britt
S&P 500 retests its one-decade breakout point 10:37 a.m. June 24, 2013 - Michael Ashbaugh
ViroPharma soars on buyout rumors 1:27 p.m. June 17, 2013 - Russ Britt
Market post-mortem: Big biotechs spike as Street warming to firms 4:43 p.m. April 12, 2013 - Russ Britt
Blood disease medication earns ViroPharma upbeat analyst reviews 12:43 p.m. March 27, 2013 - Russ Britt
Ratings hit three health firms; upgrade helps one 6:12 p.m. Jan. 15, 2013 - Russ Britt
Friday’s biggest gaining and declining stocks 3:14 p.m. Sept. 21, 2012 - Greg Morcroft
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com
ViroPharma up 15% on FDA nod 2:25 p.m. Aug. 6, 2012 - Val Brickates Kennedy
ViroPharma has FDA nod to expand Cinryze 1:19 p.m. Aug. 6, 2012 - MarketWatch.com
Knight Capital, E-Trade options volumes soar 10:06 a.m. Aug. 2, 2012 - blogs.marketwatch.com
Benzinga's M&A Chatter for Monday November 11, 2013 5:31 p.m. Today - benzinga.com
ViroPharma Larger Than S&P 500 Component JDS Uniphase 4:39 p.m. Today - TheStreet.com
Shire Buying ViroPharma To Rule Rare Disease Market 4:18 p.m. Today - Investors Business Daily
ViroPharma Gets Bought Out; Medicines Clears Entry 4:13 p.m. Today - Investors Business Daily
Intel Buys ‘Kno’ to Reinforce Education Laptops Sideline and 2 Other Hot Stocks to Watch 11:35 a.m. Today - Wall St. Cheat Sheet
Shire's Growth Carries Swollen Price Tag 11:27 a.m. Today - WSJ.com
Shire Acquiring ViroPharma; Both Stocks Hit Highs 9:57 a.m. Today - Investors Business Daily
Mid-Morning Market Update: Markets Edge Higher; Shire To Acquire ViroPharma For $4.2B 9:37 a.m. Today - benzinga.com
Shire Shells Out $4.2B to Buy ViroPharma 9:15 a.m. Today - FOXBusiness
Morning Market Movers 9:11 a.m. Today - benzinga.com
Shire Buys ViroPharma for $4.2 Billion 8:02 a.m. Today - WSJ.com
Today's Pre-Market Mover With Heavy Volume: ViroPharma (VPHM) 7:48 a.m. Today - TheStreet.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Today - 247WallSt.com
Shire Buying Viropharma for $4.2B to Bolster Rare Disease Unit 6:34 a.m. Today - TheStreet.com
Wall Street Breakfast: Must-Know News 6:34 a.m. Today - Seeking Alpha
The Deal: Shire to Spend $4.2 Billion on ViroPharma 6:33 a.m. Today - TheStreet.com
Nov. 11 Premarket Briefing: 10 Things You Should Know 5:54 a.m. Today - TheStreet.com
The Deal: Overseas Stocks Trade Mixed; Nikkei Rises 1.3% 5:43 a.m. Today - TheStreet.com
Shire to Acquire ViroPharma for $50,00/Share in Cash 5:09 a.m. Today - benzinga.com
ViroPharma's Core Business Is Accelerating, New Opportunities Emerge 11:33 a.m. Nov. 6, 2013 - Seeking Alpha
Harwood Feffer LLP Announces Investigation of ViroPharma, Inc. 5:24 p.m. Today - PR Newswire
SHAREHOLDER ALERT: Law Firm Brower Piven Announces Investigation of Possible Breaches of Fiduciary Duty by Directors of ViroPharma Incorporated in Connection with Proposed Buyout 4:09 p.m. Today - BusinessWire
Finkelstein Thompson LLP Announces Investigation of ViroPharma Inc. Buyout Proposal 3:23 p.m. Today - BusinessWire
VIROPHARMA INCORPORATED SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2:33 p.m. Today - BusinessWire
ViroPharma Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Shire 12:17 p.m. Today - BusinessWire
LEVI & KORSINSKY, LLP Investigates VIROPHARMA, INC. Board of Directors for Possible Breaches of Fiduciary Duty In Connection With Sale Of Company to Shire PLC 11:15 a.m. Today - BusinessWire
VIROPHARMA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ViroPharma Inc. (VPHM) Over the Proposed Sale of the Company to Shire (SHPG) in a Cash Deal 11:14 a.m. Today - BusinessWire
Law Firm Brower Piven Announces Investigation of ViroPharma Incorporated Proposed Buyout 11:08 a.m. Today - BusinessWire
Block & Leviton LLP Investigates ViroPharma Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Shire PLC. 10:42 a.m. Today - PR Newswire
GOGO, CLDX, VPHM and ARNA Added to NASDAQ Active Stock Watch List at EPR 10:15 a.m. Today - ACCESSWIRE
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ViroPharma, Inc. 8:45 a.m. Today - PR Newswire
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects 2:00 a.m. Today - PR Newswire
ViroPharma Announces Upcoming Data Presentations at the 2013 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting 2:29 p.m. Nov. 6, 2013 - PR Newswire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ViroPharma Incorporated Reports Third Quarter 2013 Financial Results 6:30 a.m. Oct. 31, 2013 - PR Newswire
ViroPharma To Release 2013 Third Quarter Financial Results On October 31, 2013 11:00 a.m. Oct. 28, 2013 - PR Newswire
ViroPharma To Participate In The Leerink Swann Rare Disease Conference 10:00 a.m. Sept. 27, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on ONCY, RMTI, TEVA and VPHM 8:01 a.m. Sept. 16, 2013 - ACCESSWIRE
ViroPharma To Participate In The Stifel Nicolaus 2013 Healthcare Conference 2:00 p.m. Sept. 9, 2013 - PR Newswire
RDInvesting Provides Investors with Free In-Depth Equity Reports on STMP, SRDX, VMC and VPHM 7:41 a.m. Aug. 2, 2013 - ACCESSWIRE
(0)
(0)